Yorktown Management & Research Company’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,360
Closed -$597K 219
2023
Q2
$597K Hold
6,360
0.64% 53
2023
Q1
$431K Hold
6,360
0.47% 85
2022
Q4
$315K Hold
6,360
0.39% 128
2022
Q3
$207K Buy
+6,360
New +$262K 0.27% 169
2021
Q4
Sell
-2,440
Closed -$233K 257
2021
Q3
$233K Buy
+2,440
New +$258K 0.18% 239
2015
Q4
Sell
-12,300
Closed -$221K 411
2015
Q3
$221K Hold
12,300
0.04% 387
2015
Q2
$366K Buy
+12,300
New +$309K 0.06% 172

Other funds holding EXAS

Yorktown Management & Research Company's EXAS Position: Q3 2023 in Review

Yorktown Management & Research Company sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 6,360 shares — an estimated $597K sold.

Yorktown Management & Research Company first reported a position in EXAS in Q2 2015 and held it in 7 quarters. The position peaked at $597K in Q2 2023. 625 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Yorktown Management & Research Company reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Yorktown Management & Research Company sold 6,360 Exact Sciences shares in Q3 2023, an estimated $597K.
  • Yorktown Management & Research Company first reported a position in Exact Sciences in Q2 2015 and held it in 7 quarters.
  • Yorktown Management & Research Company's Exact Sciences position peaked at $597K in Q2 2023.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Yorktown Management & Research Company's 13F filing for Q3 2023, filed 26 Oct 2023.